NEW YORK (GenomeWeb) – GenetWorx said today that it has been certified by New York State to perform its drug-response genetic testing service on samples collected in the state.
The certification means Glen Allen, Va.-based GenetWorx is able to provide the test to patients in all 50 states in the US, it said. The lab is also CLIA certified.
Called the GenetWorx DNA Drug-Response Panel, the testing panel includes assays for drug metabolizing enzymes and cardiac disease risk factors. It examines a patient's genetic metabolizer type for several cytochrome 450 enzymes that activate many commonly prescribed cardiology, pain management, and psychiatry medications.
GenetWorx was founded in 2012 and provides DNA analysis for use by clinicians to support treatment decisions. In December 2013, its clinical lab received accreditation from the College of American Pathologists.